Revenue: The sum of all revenue fields included for a company's operating activities.
Ensysce Biosciences, Inc. (ENSC) had Revenue of $1.32M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$1.32M |
$-1.95M |
|
-- |
|
$1.32M |
|
$3.29M |
|
$-1.97M |
|
$0.02M |
|
$-1.95M |
|
$-1.95M |
|
$-1.95M |
|
$-1.95M |
|
$-1.95M |
|
$-1.95M |
|
$-1.97M |
|
$-1.97M |
|
1.40M |
|
1.40M |
|
$-1.39 |
|
$-1.39 |
|
| Balance Sheet Financials | |
$4.40M |
|
-- |
|
$0.21M |
|
$4.61M |
|
$1.76M |
|
-- |
|
$0.13M |
|
$1.89M |
|
$2.72M |
|
$2.72M |
|
$2.72M |
|
1.65M |
|
| Cash Flow Statement Financials | |
$-1.71M |
|
-- |
|
$1.26M |
|
$3.50M |
|
$3.05M |
|
$-0.45M |
|
$0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.50 |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
100.00% |
|
-149.08% |
|
-149.08% |
|
-- |
|
-147.42% |
|
-147.42% |
|
$-1.71M |
|
-- |
|
-- |
|
-- |
|
0.29 |
|
-- |
|
59.98 |
|
1.50 |
|
-71.51% |
|
-71.51% |
|
-42.19% |
|
-71.51% |
|
$1.65 |
|
$-1.22 |
|
$-1.22 |
|